Phenotypic lentivirus screens to identify functional single domain antibodies

Nature Microbiology

Volumn 1, Issue 8, 2016, Pages

  Schmidt, Florian I ^a   Hanke, Leo ^a   Morin, Benjamin ^b,d   Brewer, Rebeccah ^a   Brusic, Vesna ^b   Whelan, Sean P J ^b   Ploegh, Hidde L ^a,c  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Antigenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NANOBODY;

A-549 CELL LINE; HUMAN; INFLUENZA A VIRUS; ISOLATION AND PURIFICATION; PATHOGENICITY; PRECLINICAL STUDY; PROCEDURES; VESICULOVIRUS;

A549 CELLS; ANTIVIRAL AGENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; INFLUENZA A VIRUS; SINGLE-DOMAIN ANTIBODIES; VESICULOVIRUS;

EID: 84991406521     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.80     Document Type: Article

References (39)

1. Mohr, S. E., Smith, J. A., Shamu, C. E., Neumuller, R. A. & Perrimon, N. RNAi screening comes of age: improved techniques and complementary approaches. Nature Rev. Mol. Cell Biol. 15, 591-600 (2014).
2. Kim, H. & Kim, J. S. A guide to genome engineering with programmable nucleases. Nature Rev. Genet. 15, 321-334 (2014).
3. Cohen, P. Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 425, 53-54 (2010).
4. Doxsey, S. J., Brodsky, F. M., Blank, G. S. & Helenius, A. Inhibition of endocytosis by anti-clathrin antibodies. Cell 50, 453-463 (1987).
5. Gargano, N. & Cattaneo, A. Rescue of a neutralizing anti-viral antibody fragment from an intracellular polyclonal repertoire expressed in mammalian cells. FEBS Lett. 414, 537-540 (1997).
6. Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446-448 (1993).
7. Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 82, 775-797 (2013).
8. Helma, J., Cardoso, M. C., Muyldermans, S. & Leonhardt, H. Nanobodies and recombinant binders in cell biology. J. Cell Biol. 209, 633-644 (2015).
9. Schmidt, F. I. et al. A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly. J. Exp. Med. 213, 771-790 (2016).
10. Maass, D. R., Sepulveda, J., Pernthaner, A. & Shoemaker, C. B. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). J. Immunol. Methods 324, 13-25 (2007).
11. Ryckaert, S., Pardon, E., Steyaert, J. & Callewaert, N. Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris. J. Biotechnol. 145, 93-98 (2010).
12. Fridy, P. C. et al. A robust pipeline for rapid production of versatile nanobody repertoires. Nature Methods 11, 1253-1260 (2014).
13. Ashour, J. et al. Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization. J. Virol. 89, 2792-2800 (2015).
14. Dougan, S. K. et al. Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature 503, 406-409 (2013).
15. Barrios-Rodiles, M. et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307, 1621-1625 (2005).
16. Guimaraes, C. P. et al. Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions. Nature Protoc. 8, 1787-1799 (2013).
17. Fodor, E. The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication. Acta Virol. 57, 113-122 (2013).
18. Lyles, D. S. & Rupprecht, C. E. in Fields' Virology (eds Fields, B. N. et al. 1364-1408 (Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007).
19. Emerson, S. U. & Wagner, R. R. Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J. Virol. 10, 297-309 (1972).
20. Green, T. J. & Luo, M. Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P. Proc. Natl Acad. Sci. USA 106, 11713-11718 (2009).
21. Rahmeh, A. A. et al. Molecular architecture of the vesicular stomatitis virus RNA polymerase. Proc. Natl Acad. Sci. USA 107, 20075-20080 (2010).
22. Baltimore, D., Huang, A. S. & Stampfer, M. Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc. Natl Acad. Sci. USA 66, 572-576 (1970).
23. Li, T. et al. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging. FASEB J. 26, 3969-3979 (2012).
24. Morin, B., Kranzusch, P. J., Rahmeh, A. A. & Whelan, S. P. The polymerase of negative-stranded RNA viruses. Curr. Opin. Virol. 3, 103-110 (2013).
25. Yewdell, J. W., Frank, E. & Gerhard, W. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126, 1814-1819 (1981).
26. Sosa, B. A. et al. How lamina-associated polypeptide 1 (LAP1) activates torsin. eLife 3, e03239 (2014).
27. Meerbrey, K. L. et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665-3670 (2011).
28. Lefrancois, L. & Lyles, D. S. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121, 157-167 (1982).
29. Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150, 987-1001 (2012).
30. Conrath, K. E. et al. Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob. Agents Chemother. 45, 2807-2812 (2001).
31. Andersen, K. R., Leksa, N. C. & Schwartz, T. U. Optimized E. coli expression strain LOBSTR eliminates common contaminants from His-tag purification. Proteins 81, 1857-1861 (2013).
32. Green, T. J. et al. Access to RNA encapsidated in the nucleocapsid of vesicular stomatitis virus. J. Virol. 85, 2714-2722 (2011).
33. Kamentsky, L. et al. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 27, 1179-1180 (2011).
34. Schickli, J. H. et al. Plasmid-only rescue of influenza A virus vaccine candidates. Phil Trans. R. Soc. Lond. B 356, 1965-1973 (2001).
35. Fodor, E. et al. Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679-9682 (1999).
36. Pattnaik, A. K. & Wertz, G. W. Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J. Virol. 64, 2948-2957 (1990).
37. Lehrach, H., Diamond, D., Wozney, J. M. & Boedtker, H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16, 4743-4751 (1977).
38. Morin, B., Rahmeh, A. A. & Whelan, S. P. Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase. EMBO J. 31, 1320-1329 (2012).
39. Cherry, S. et al. Genome-wide RNAi screen reveals a specific sensitivity of IREScontaining RNA viruses to host translation inhibition. Genes Dev. 19, 445-452 (2005).